The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.
Open accessAbstract
The mature gag and pol proteins of human immunodeficiency virus (HIV) and all retroviruses derive from large gag and gag-pol polyprotein precursors by posttranslational cleavage. A highly specific, virally encoded protease is required for this essential proteolytic processing. In this study, the HIV protease gene product was expressed in Escherichia coli and shown to autocatalyze its maturation from a larger precursor. In addition, this bacterially produced HIV protease specifically processed an HIV p55 gag polyprotein precursor when coexpressed in E. coli. This system will allow detailed structure-function analysis of the HIV protease and provides a simple assay for the development of potential therapeutic agents directed against this critical viral enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R., Oleske, J., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,641
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Nucleotide Sequence and Expression of an AIDS-Associated Retrovirus (ARV-2)
Sanchez-Pescador, R., Power, M. D., Barr, P. J., Steimer, K. S., Stempien, M. M., Brown-Shimer, S. L., Gee, W. W., Renard, A., Randolph, A., Levy, J. A., et al. (1985) · Science · doi:10.1126/science.2578227 · Cited by 719
Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus
Muesing, M. A., Smith, D. H., Cabradilla, C. D., Benton, C. V., Lasky, L. A., & Capon, D. J. (1985) · Nature · doi:10.1038/313450a0 · Cited by 682
Shaw, G. M., Hahn, B. H., Arya, S. K., Groopman, J. E., Gallo, R. C., & Wong-Staal, F. (1984) · Science · doi:10.1126/science.6095449 · Cited by 633
Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV
di Marzo Veronese, F., Copeland, T. D., DeVico, A. L., Rahman, R., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1986) · Science · doi:10.1126/science.2418504 · Cited by 545
Yoshinaka, Y., Katoh, I., Copeland, T. D., & Oroszlan, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1618 · Cited by 335
Cited by
Molecular and Biotechnological Aspects of Microbial Proteases
Rao, M. B., Tanksale, A. M., Ghatge, M. S., & Deshpande, V. V. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.3.597-635.1998 · Cited by 2,271
Active human immunodeficiency virus protease is required for viral infectivity
Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4686 · Cited by 1,307
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
Navia, M. A., Fitzgerald, P. M. D., McKeever, B. M., Leu, C.-T., Heimbach, J. C., Herber, W. K., Sigal, I. S., Darke, P. L., & Springer, J. P. (1989) · Nature · doi:10.1038/337615a0 · Cited by 894
INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design
Wlodawer, A., & Vondrasek, J. (1998) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.27.1.249 · Cited by 734
DNA microarrays in drug discovery and development
Debouck, C., & Goodfellow, P. N. (1999) · Nature Genetics · doi:10.1038/4475 · Cited by 652
Self-citationProline-Dependent Structural and Biological Properties of Peptides and Proteins
Yaron, A., Naider, F., & Scharpe, S. (1993) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239309082572 · Cited by 551
Structural biology of HIV 1 1Edited by P. E. Wright
Turner, B. G., & Summers, M. F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2354 · Cited by 470
Nucleotide sequence and genomic organization of feline immunodeficiency virus.
Talbott, R. L., Sparger, E. E., Lovelace, K. M., Fitch, W. M., Pedersen, N. C., Luciw, P. A., & Elder, J. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5743 · Cited by 384
A Synthetic HIV-1 Protease Inhibitor with Antiviral Activity Arrests HIV-Like Particle Maturation
McQuade, T. J., Tomasselli, A. G., Liu, L., Karacostas, V., Moss, B., Sawyer, T. K., Heinrikson, R. L., & Tarpley, W. G. (1990) · Science · doi:10.1126/science.2405486 · Cited by 374
Peng, C., Ho, B. K., Chang, T. W., & Chang, N. T. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2550-2556.1989 · Cited by 371
Race, E. M., Adelson-Mitty, J., Kriegel, G. R., Barlam, T. F., Reimann, K. A., Letvin, N. L., & Japour, A. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)04352-3 · Cited by 358
Enzyme Kinetics Determined Using Calorimetry: A General Assay for Enzyme Activity?
Todd, M. J., & Gomez, J. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5218 · Cited by 351
Dougherty, W. G., & Semler, B. L. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.4.781-822.1993 · Cited by 345
The HIV-1 Protease as a Therapeutic Target for AIDS
DEBOUCK, C. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.153 · Cited by 341
Self-citationCunningham, D. F., & O'Connor, B. (1997) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00134-9 · Cited by 336
Complete mutagenesis of the HIV-1 protease
Loeb, D. D., Swanstrom, R., Everitt, L., Manchester, M., Stamper, S. E., & Hutchison, C. A. (1989) · Nature · doi:10.1038/340397a0 · Cited by 327
Le GRICE, S. F. J., & GRÜNINGER‐LEITCH, F. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15306.x · Cited by 329
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Seelmeier, S., Schmidt, H., Turk, V, & von der Helm, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6612 · Cited by 328
Wang, W., & Kollman, P. A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4057 · Cited by 322
The Race against Protease Activation Defines the Role of ESCRTs in HIV Budding
Bendjennat, M., & Saffarian, S. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005657 · Cited by 45
Metadata
- Authors
- Debouck, C., Gorniak, J. G., Strickler, J. E., Meek, T. D., Metcalf, B. W., & Rosenberg, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1987-12
- Volume
- 84
- Issue
- 24
- Pages
- 8903-8906
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2028124297
- Cited by
- 278
- References
- 17
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.